RXRX Recursion Pharmaceuticals In

held by 1 manager in Q4 2022

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.53%	1.5 yr	—	$11M	1,385,950

Search